CD40/IL4 may preferentially induce BclxL and Bfl-1 expression over Mcl-1 in CLL, and these are also likely reduced by inhibition of the BCR pathway [30]. The gene discussed is MCL1; the disease is B-cell chronic lymphocytic leukemia.